Active matrix metalloproteinase-8 and interleukin-6 detect periodontal degeneration caused by radiotherapy of head and neck cancer: A pilot study
dc.contributor.author | Keskin, Mutlu | |
dc.contributor.author | Lahteenmaki, Hanna | |
dc.contributor.author | Rathnayake, Nilminie | |
dc.contributor.author | Raisanen, Ismo T. | |
dc.contributor.author | Tervahartiala, Taina | |
dc.contributor.author | Parnanen, Pirjo | |
dc.contributor.author | Sorsa, Timo | |
dc.date.accessioned | 2021-05-15T11:33:17Z | |
dc.date.available | 2021-05-15T11:33:17Z | |
dc.date.issued | 2020 | |
dc.department | Diş Hekimliği Fakültesi | en_US |
dc.description | Raisanen, Ismo/0000-0001-5821-5299; Hagstrom, Jaana/0000-0001-6079-7881; Heikkila, Pia/0000-0002-5925-1993; Gursoy, Ulvi Kahraman/0000-0002-1225-5751 | |
dc.description.abstract | Background: This cohort study investigated the role of the active matrix metalloproteinase-8 (aMMP-8) and interleukin-6 (IL-6) as oral fluid biomarkers for monitoring the periodontal degeneration occurring in head and neck cancer (HNC) patients treated by radiotherapy. Research design and methods: Eleven patients, aged 28-74, diagnosed with HNC were included in the study. Complete periodontal and oral examinations were performed pre-radiotherapy and 1 month after radiotherapy. Mouthrinse samples (pre-radiotherapy, after 6 weeks of radiotherapy and 1 month after radiotherapy) were assayed by aMMP-8 point-of-care-kit (PerioSafe (R)/ORALyzer (R)) for aMMP-8 and ELISA for IL-6. Results: HNC radiotherapy had a deteriorating impact on the periodontium and a significant impact on periodontal biomarkers aMMP-8 and IL-6 and increased their levels in mouthrinse. Clinical-attachment-loss (CAL) (site of greatest loss: mean = 1.7 mm, range = 1-3 mm) corresponding to rapid progression of periodontitis. There was a positive repeated measures correlation (rmcorr = 0.667) between the aMMP-8 and IL-6 levels. Conclusions: Elevated aMMP-8 levels were observed 1 month after radiotherapy among some HNC patients suggesting a prolonged increased susceptibility to further periodontal tissue destruction. Currently available aMMP-8 point-of-care testing could be useful to monitor and assess quantitatively online and real-time the risk of deterioration of periodontal health during HNC radiotherapy. | en_US |
dc.description.sponsorship | Helsinki University Hospital, Helsinki, Finland [TYH2016251, TYH2017251, TYH2018229, TYH2019319, Y1014SL017, Y1014SL018, Y1014SULE1]; Karolinska Institute, Stockholm, SwedenKarolinska Institutet | en_US |
dc.description.sponsorship | This research was funded by the Helsinki University Hospital, Helsinki, Finland (grant numbers: TYH2016251, TYH2017251, TYH2018229, TYH2019319, Y1014SL017, Y1014SL018, Y1014SULE1), and the Karolinska Institute, Stockholm, Sweden. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. | en_US |
dc.identifier.doi | 10.1080/14789450.2020.1858056 | |
dc.identifier.endpage | 784 | en_US |
dc.identifier.issn | 1478-9450 | |
dc.identifier.issn | 1744-8387 | |
dc.identifier.issue | 10 | en_US |
dc.identifier.pmid | 33406924 | |
dc.identifier.scopus | 2-s2.0-85099187563 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 777 | en_US |
dc.identifier.uri | https://doi.org/10.1080/14789450.2020.1858056 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12939/121 | |
dc.identifier.volume | 17 | en_US |
dc.identifier.wos | WOS:000605385500001 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.institutionauthor | Keskin, Mutlu | |
dc.language.iso | en | |
dc.publisher | Taylor & Francis Ltd | en_US |
dc.relation.ispartof | Expert Review of Proteomics | |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | aMMP-8 | en_US |
dc.subject | Head And Neck Cancer | en_US |
dc.subject | Il-6 | en_US |
dc.subject | Periodontitis | en_US |
dc.subject | Point Of Care Technology | en_US |
dc.subject | Radiotherapy | en_US |
dc.title | Active matrix metalloproteinase-8 and interleukin-6 detect periodontal degeneration caused by radiotherapy of head and neck cancer: A pilot study | |
dc.type | Review Article |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- Active matrix metalloproteinase-8 and interleukin-6 detect periodontal degeneration caused by radiotherapy of head and neck cancer A pilot study.pdf
- Boyut:
- 1.16 MB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin/ Full Text